Asymmetry Capital Management, L.P. - SYNERGY PHARMACEUTICALS DEL ownership

SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 151 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q4 2017. The put-call ratio across all filers is 1.99 and the average weighting 0.0%.

Quarter-by-quarter ownership
Asymmetry Capital Management, L.P. ownership history of SYNERGY PHARMACEUTICALS DEL
ValueSharesWeighting
Q4 2017$1,065,000
+35.5%
477,621
+76.2%
1.44%
+58.4%
Q3 2017$786,000
-52.6%
271,102
-27.3%
0.91%
-53.6%
Q2 2017$1,658,000
-67.4%
372,694
-65.9%
1.97%
-72.3%
Q1 2017$5,088,000
+50.5%
1,091,768
+96.7%
7.09%
+12.9%
Q4 2016$3,380,000
+80.9%
555,085
+63.7%
6.28%
+93.5%
Q3 2016$1,868,000
+64.9%
339,068
+13.7%
3.25%
+56.5%
Q2 2016$1,133,000
-34.1%
298,190
-1.6%
2.08%
-20.1%
Q4 2015$1,719,000
+59.6%
303,157
+49.2%
2.60%
+8.3%
Q3 2015$1,077,000203,1552.40%
Other shareholders
SYNERGY PHARMACEUTICALS DEL shareholders Q4 2017
NameSharesValueWeighting ↓
Nantahala Capital Management 11,578,568$20,147,0000.82%
Virtus ETF Advisers LLC 441,461$768,0000.68%
Hikari Power Ltd 2,300,000$4,002,0000.44%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,403,149$2,441,0000.17%
KNOTT DAVID M 225,400$392,0000.15%
Clear Harbor Asset Management, LLC 277,110$482,0000.09%
Malaga Cove Capital, LLC 97,264$169,0000.09%
Lehman Financial Resources, Inc. 80,800$140,0000.07%
Cheyne Capital Management (UK) LLP 50,000$87,0000.06%
Ballew Advisors, Inc 26,200$46,0000.05%
View complete list of SYNERGY PHARMACEUTICALS DEL shareholders